Data Bytes: CHMP’s September recommendations

EMA’s CHMP endorsed the use of dexamethasone as treatment for hospitalized COVID-19 patients who require oxygen therapy. The recommendation came with the agency’s latest round of opinions Friday.

In the adaptive RECOVERY trial, the steroid reduced COVID-19 deaths by 35% in ventilated patients and by 20% in patients on oxygen support; the U.K. approved dexamethasone for COVID-19 in June (see “U.K. Approves Steroid”). ...